Does Rifampin Interact with Empagliflozin And Linagliptin?
Rifampin and Empagliflozin And Linagliptin have a major drug interaction according to U.S. FDA drug labeling data. Strong P-gp or CYP3A4 inducer decreases linagliptin exposure and may reduce efficacy. Alternative treatments strongly recommended. The mechanism involves induction of p-glycoprotein or cyp3a4 enzymes, decreasing linagliptin exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Major
- Rifampin Class
- Rifamycin Antibacterial
- Empagliflozin And Linagliptin Class
- Dipeptidyl Peptidase 4 Inhibitor
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Rifampin and Empagliflozin And Linagliptin occurs because induction of p-glycoprotein or cyp3a4 enzymes, decreasing linagliptin exposure. Clinically, this means strong p-gp or cyp3a4 inducer decreases linagliptin exposure and may reduce efficacy. alternative treatments strongly recommended. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.
What To Tell Your Doctor or Pharmacist
If you are taking Rifampin and your doctor is considering prescribing Empagliflozin And Linagliptin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider